EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieOpen Access · CC BY 4.0

Multicenter Study on Tumor Budding in Lung Squamous Cell Carcinoma: Comparison Between Biopsy and Resection With Interobserver Variability Assessment

Marie Maillard, Christina Neppl, Philipp Zens, Julie Anex, Solange Peters, Thorsten Krueger, Sabina Berezowska

Modern Pathology · 2024

DOI: 10.1016/j.modpat.2024.100571 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Modern Pathology, 2024. Verfasst von Marie Maillard und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Observer Variation, Lung Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Grading lung squamous cell carcinoma (LUSC) is controversial and not universally accepted. The histomorphologic feature of tumor budding (TB) is an established independent prognostic factor in colorectal cancer, and its importance is growing in other solid cancers, making it a candidate for inclusion in tumor grading schemes. We aimed to compare TB between preoperative biopsies and resection specimens in pulmonary squamous cell carcinoma and assess interobserver variability. A retrospective cohort of 249 consecutive patients primarily resected with LUSC in Bern (2000-2013, n = 136) and Lausanne (2005-2020, n = 113) with available preoperative biopsies was analyzed for TB and additional histomorphologic parameters, such as spread through airspaces and desmoplasia, by 2 expert pathologists (M.M., C.N.). Results were correlated with clinicopathologic parameters and survival. In resection specimens, peritumoral budding (PTB) score was low (0-4 buds/0.785 mm2) in 47.6%, intermediate (5-9 buds/0.785 mm2) in 27.4%, and high (≥10 buds/0.785 mm2) in 25% of cases (median bud count, 5; IQR, 0-26). Both the absolute number of buds and TB score were similar when comparing tumor edge and intratumoral zone (P = .192) but significantly different from the score obtained in the biopsy (P < .001). Interobserver variability was moderate, regardless of score location (Cohen kappa, 0.59). The discrepant cases were reassessed, and consensus was reached in all cases with identification of causes of discordance. TB score was significantly associated with stage (P = .002), presence of lymph node (P = .033), and distant metastases (P = .020), without significant correlation with overall survival, tumor size, or pleural invasion. Desmoplasia was significantly associated with higher PTB (P < .001). Spread through airspaces was present in 34% and associated with lower PTB (P < .001). To conclude, despite confirming TB as a reproducible factor in LUSC, we disclose areas of scoring ambiguity. Preoperative biopsy evaluation was insufficient in establishing the final TB score of the resected tumor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Observer VariationLung NeoplasmsCarcinoma, Squamous CellHumansFemaleMaleAgedRetrospective StudiesMiddle AgedBiopsyNeoplasm GradingAged, 80 and over

Stichwörter der Autor:innen

biopsyinterobserver variabilitylung cancernon–small cell lung carcinomapreoperativesquamous cell carcinomatumor budding

Autor:innen und Institutionen

  • Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Institute of Pathology, Heinrich-Heine University and University Hospital of Duesseldorf, Germany; Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland.
  • Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland; Graduate School for Health Science, University of Bern, Bern, Switzerland.
  • Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Department of Thoracic Surgery, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Electronic address: sabina.berezowska@chuv.ch.

Förderung

  • Swiss National Science Foundation

Zitieren

APA

Maillard, M., Neppl, C., Zens, P., Anex, J., Peters, S., Krueger, T., & Berezowska, S. (2024). Multicenter Study on Tumor Budding in Lung Squamous Cell Carcinoma: Comparison Between Biopsy and Resection With Interobserver Variability Assessment. Modern Pathology. https://doi.org/10.1016/j.modpat.2024.100571

Vancouver

Maillard M, Neppl C, Zens P, Anex J, Peters S, Krueger T, et al. Multicenter Study on Tumor Budding in Lung Squamous Cell Carcinoma: Comparison Between Biopsy and Resection With Interobserver Variability Assessment. Modern Pathology. 2024. doi:10.1016/j.modpat.2024.100571

BibTeX
@article{Maillard2024,
  author = {Maillard, Marie and Neppl, Christina and Zens, Philipp and Anex, Julie and Peters, Solange and Krueger, Thorsten and Berezowska, Sabina},
  title = {Multicenter Study on Tumor Budding in Lung Squamous Cell Carcinoma: Comparison Between Biopsy and Resection With Interobserver Variability Assessment},
  journal = {Modern Pathology},
  year = {2024},
  doi = {10.1016/j.modpat.2024.100571}
}
Kostenlos starten →